1479 related articles for article (PubMed ID: 19474675)
21. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
22. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
23. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
24. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
25. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.
Haigh PI; Urbach DR; Rotstein LE
Surgery; 2004 Sep; 136(3):609-16. PubMed ID: 15349109
[TBL] [Abstract][Full Text] [Related]
26. Childhood and adolescent thyroid carcinoma.
Grigsby PW; Gal-or A; Michalski JM; Doherty GM
Cancer; 2002 Aug; 95(4):724-9. PubMed ID: 12209714
[TBL] [Abstract][Full Text] [Related]
27. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
[TBL] [Abstract][Full Text] [Related]
28. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis.
Besic N; Auersperg M; Golouh R
Eur J Surg Oncol; 1999 Dec; 25(6):599-605. PubMed ID: 10556007
[TBL] [Abstract][Full Text] [Related]
30. Predictors of thyroid tumor aggressiveness.
Clark OH
West J Med; 1996 Sep; 165(3):131-8. PubMed ID: 8909165
[TBL] [Abstract][Full Text] [Related]
31. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
32. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
Thyroid; 2012 Aug; 22(8):798-804. PubMed ID: 22853727
[TBL] [Abstract][Full Text] [Related]
33. Differentiated thyroid cancer and outcome in iodine deficiency.
Gyory F; Balazs G; Nagy EV; Juhasz F; Mezosi E; Szakall S; Math J; Lukacs G
Eur J Surg Oncol; 2004 Apr; 30(3):325-31. PubMed ID: 15028317
[TBL] [Abstract][Full Text] [Related]
34. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
[TBL] [Abstract][Full Text] [Related]
35. Long-term results in elderly patients with differentiated thyroid carcinoma.
Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer.
Kushchayeva Y; Duh QY; Kebebew E; D'Avanzo A; Clark OH
Am J Surg; 2008 Apr; 195(4):457-62. PubMed ID: 18070728
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors influencing survival after surgical treatment of well differentiated thyroid cancer].
Nowak W; Szybiński P; Nowak K; Stachura J; Popiela T
Wiad Lek; 2004; 57(9-10):431-7. PubMed ID: 15765757
[TBL] [Abstract][Full Text] [Related]
38. Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.
Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Yuen KT; Law CC; Lau WH
Cancer; 2002 Aug; 95(3):488-98. PubMed ID: 12209740
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
40. [The significance of lymph node status in papillary and follicular thyroid gland carcinoma for the nuclear medicine physician].
Farahati J; Mörtl M; Reiners C
Zentralbl Chir; 2000; 125(10):830-4. PubMed ID: 11098578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
